WIC is changing in 2024. Here's what to expect

The USDA's WIC program supports more than 6 million women, children, and infants. A new rule will give participants healthier food options as of June 2024.

Infant formula, baby food could soon be safer

The causes and effects of the recent powdered infant formula shortage

FDA releases internal report on its response to the infant formula crisis

The report focuses on the crisis that left parents scouring supermarket shelves for infant and specialty formulas for much of the spring and summer, but cuts much deeper, shining a self-critical spotlight on the many issues that have plagued the agency.

Senate HELP Committee passes FDA user fee bill, including new oversight of infant formula, medical foods

The bill comes with provisions to help ensure that infant formula is free from contamination, and that FDA has adequate warning of problems that could lead to shortages of formula and other specialized medical foods.

CSPI urges policymakers in Washington to deploy additional tools to address the infant formula crisis

CSPI calls on the White House and policymakers at FDA and in Congress to use all the tools at their disposal to address the immediate crisis.

CSPI calls on Abbott and FDA to clarify the scope of the infant formula recall

Abbott and the Food and Drug Administration should clarify which infant formula products are part of a recall from Abbott’s Sturgis, Michigan facility, which is being investigated after five infant illnesses and two deaths that may have been caused by Cronobacter infection from contaminated formula.

FDA urged to stop formula companies from selling sugary drinks as “formula” to toddlers

The Food and Drug Administration should take enforcement action against three prominent infant formula manufacturers for marketing sugary drinks to toddlers up to three years old, according to an enforcement request sent to the agency today.

CSPI and Rudd Center FDA Request for Enforcement re: Toddler Milks and Transition Formulas

The Center for Science in the Public Interest (CSPI), the UConn Rudd Center for Food Policy & Obesity, and Dr. Jennifer Pomeranz, JD, MPH, Assistant Professor, New York University, submitted this letter to urge the Food and Drug Administration to take immediate enforcement action against the marketing of misbranded products that are labeled as infant formula but are marketed for use by children over 12 months, including the products highlighted in this letter.

Acrylamide in Infant Formula Petition